BIOCORP signs exclusive deal with VITROBIO PHARMA
(WorldNews France)

Press release BIOCORP signs exclusive deal with VITROBIO PHARMA to produce the first drug treatment against allergy related to pollution The exclusive agreement between the two companies is for a period of 10 years Estimated turnover: more than EUR10 million over 10 years BIOCORP invests 600 KEUR in a new fully automated production line dedicated to this new health device Issoire, November 15, 2019, at 7:30 am CEST - BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specializing in the development and manufacturing of medical devices and smart drug delivery systems, announces today the signature of an exclusive contract with VITROBIO PHARMA, a pharmaceutical research and...